• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,702.98 -735.30
(-1.55%)
Dow Jones
6,694.68 -102.12
(-1.50%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,300.41 -53.36
(-0.52%)
Forex
USD-INR
91.92 0.02
(0.02%)
EUR-INR
106.58 -0.28
(-0.27%)
GBP-INR
123.39 -0.12
(-0.10%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Indifra Ltd
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
91807
INE0PS301014
24.9163237
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDIFRA
1485
10.83
EPS(TTM)
Face Value()
Div & Yield %
0.01
10
0
 

Valiant Laboratories reports consolidated net loss of Rs 7.06 crore in the December 2025 quarter
Feb 11,2026
Net loss of Valiant Laboratories reported to Rs 7.06 crore in the quarter ended December 2025 as against net profit of Rs 2.35 crore during the previous quarter ended December 2024. Sales rose 48.91% to Rs 52.46 crore in the quarter ended December 2025 as against Rs 35.23 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales52.4635.23 49
OPM %-1.701.76 -
PBDT-0.942.14 PL
PBT-2.991.62 PL
NP-7.062.35 PL